JSW Dulux Q2 FY27 Results Analysis: Volumes Surge 21%, Margin Misses Guidance (JSWDULUX)

Cofacto Research Published November 04, 2026 3 min read
Negative

JSW Dulux Ltd's Q2 FY27 numbers came in soft. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateNovember 04, 2026
Revenue (Q2)Rs. 961.90 Cr (+16.23% YoY)
PAT (Q2)Rs. 71.20 Cr
EBITDA margin11.53% (-183 bps YoY)
EPS (Q2)Rs. 15.63

Quarter Snapshot

Q2 FY27 delivered 21% volume growth and 21.3% comparable revenue growth, but EBITDA margin of 11.53% missed all of management's guided bands (13-15% latest) and slipped further QoQ as raw-material costs grew 38% against 16% revenue growth. Underlying PAT grew only 2.01% on the clean basis, with growth consuming working capital (inventories +42% since March). The volume franchise and debt-free balance sheet remain intact, but the margin-repair promise due by August-September 2026 was not delivered.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
Revenue"revenue likely in line to ahead, skewed by price/mix"+16.23% reported, +21.3% comparablePlayed out
Volumedouble-digit at risk late-quarter vs a rival priced 12–18% lower+21% volumePlayed out
EBITDA margin"recovery from Q1's 11.93% toward the guided 13–15% band looks behind the Aug–Sep deadline"11.53% — below every band, down 40 bps QoQPlayed out
One-offs"Q2 reverts from the Rs.55.9 Cr dividend and Rs.21.5 Cr refund-interest base; consolidated PAT converging toward standalone"Other income Rs.2.4 Cr; consol PAT Rs.71.4 Cr vs standalone Rs.71.2 CrPlayed out
TiO2 dutyreimposition after the quarter is a Q3-onward cost item (per pre-call note, web-sourced, dated 24 Oct 2026)Not addressed in this filingNot observable
GST contingency / provisioning stancelive SCNsNot addressed in this filing — remains openNot observable

Management Guidance vs Delivery

What management saidWhereWhat happenedVerdict
EBITDA margin 13–15%Q1 FY27 earnings call, "given the crude prices"11.53%Missed
EBITDA margin 14.5–15% ex-synergiesQ3 FY26 earnings call11.53%Missed
EBITDA margin 14–16% "on a sustained basis"Q2 FY26 earnings call11.53%Missed
Margin impacts to "neutralize by August-September 2026"Q4 FY26 earnings call11.53% vs 11.93% in Q1 — slipped further, not neutralizedMissed
Double-digit volume and value growthReiterated on the Q1 FY27 call; CEO quote in the media release: "consecutive quarter of double-digit volume and value growth"Volume +21%; comparable revenue +21.3%Met
Debt-free status (maintain)Prior earnings callsNo borrowings on the 30 Sep 2026 balance sheetOn Track

Key Investment Insights

Key Positives

  • Revenue grew 16.23% YoY reported (Rs.961.9 Cr) and 21.3% on the comparable retained-business basis
  • Volume grew 21% YoY; H1 volume +23%
  • Comparable EBITDA grew 4.4% YoY (Rs.110.9 Cr vs Rs.106.3 Cr) despite raw-material inflation
  • Employee costs fell 2.62% YoY and other expenses grew 11.67% YoY, slower than revenue
  • H1 operating cash flow of Rs.141.7 Cr vs an outflow of Rs.(202.5) Cr in H1 FY26
  • Company remains debt-free with no borrowings on the 30 Sep 2026 balance sheet
  • Q2 is a clean quarter with other income of only Rs.2.4 Cr (0.25% of revenue) and no exceptional items

Risk Factors

  • EBITDA margin of 11.53% missed management's guided bands of 13-15%, 14.5-15% ex-synergies, and 14-16% sustained, and slipped 40 bps QoQ
  • Cost of materials consumed grew 38.05% YoY vs revenue growth of 16.23%; gross margin compressed to 36.78% from 40.77% LY
  • PAT-ex-exceptionals grew only 2.01% on 21% volume growth; reported EBITDA was flat (+0.27% YoY)
  • Inventories rose 42.16% since March (Rs.240.8 Cr build) and H1 CFO/PAT-ex-exceptionals was 0.686x
  • Comparable revenue growth approximating volume growth implies negative price/mix on the retained base against competitors priced 12-18% lower
  • Finance costs doubled to Rs.4.5 Cr (+95.65% YoY)
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now